UP-TO-DATE, RESEARCH BASED INFORMATION ABOUT PSYCHEDELICS. James Hawkins 01/07/2025 James Hawkins 01/07/2025 Beckley’s 5-MeO-DMT shows rapid, durable antidepressant effects in phase 2b study Read More James Hawkins 23/06/2025 James Hawkins 23/06/2025 An investigation into the varieties of extended difficulties following psychedelic drug use: Duration, severity and helpful coping strategies Read More James Hawkins 23/06/2025 James Hawkins 23/06/2025 Long-term mental health and wellbeing outcomes associated with naturalistic ayahuasca consumption Read More James Hawkins 22/06/2025 James Hawkins 22/06/2025 Shamanism and psychedelics: 5 questions for Manvir Singh Read More James Hawkins 22/06/2025 James Hawkins 22/06/2025 MAPS brings MDMA-assisted therapy to the war in Ukraine Read More James Hawkins 18/06/2025 James Hawkins 18/06/2025 An international Delphi consensus for reporting of setting in psychedelic clinical trials Read More James Hawkins 18/06/2025 James Hawkins 18/06/2025 Long-term benefits of single-dose psilocybin in depressed patients with cancer Read More James Hawkins 08/06/2025 James Hawkins 08/06/2025 Psychedelic-assisted therapy: An overview for the internist Read More James Hawkins 08/06/2025 James Hawkins 08/06/2025 Addressing blinding in classic psychedelic studies with innovative active placebos Read More James Hawkins 08/06/2025 James Hawkins 08/06/2025 The Afterglow Inventory (AGI): Validation of a new instrument for measuring subacute effects of classic serotonergic psychedelics Read More James Hawkins 01/06/2025 James Hawkins 01/06/2025 Systematic review of the effect of psychedelic-assisted therapy on … symptoms of distress, depression, and/or anxiety in patients with life-threatening illness Read More James Hawkins 01/06/2025 James Hawkins 01/06/2025 Effects of psilocybin on religious and spiritual attitudes and behaviors in clergy from various major world religions Read More James Hawkins 01/06/2025 James Hawkins 01/06/2025 Catalyst for change: Psilocybin’s antidepressant mechanisms — A systematic review Read More James Hawkins 31/05/2025 James Hawkins 31/05/2025 Impact analysis of expanded access to ketamine for treatment-resistant depression Read More James Hawkins 31/05/2025 James Hawkins 31/05/2025 Therapeutic emergence of dissociated traumatic memories during psilocybin treatment for anorexia nervosa Read More James Hawkins 31/05/2025 James Hawkins 31/05/2025 Psychedelics and nature connectedness: Potential for restoring a lost relationship Read More James Hawkins 24/05/2025 James Hawkins 24/05/2025 MDMA-assisted therapy for couples: Screening, preparation, and practice Read More James Hawkins 24/05/2025 James Hawkins 24/05/2025 Reduced brain responsiveness to emotional stimuli with escitalopram but not psilocybin therapy for depression Read More James Hawkins 24/05/2025 James Hawkins 24/05/2025 Psilocybin and neuroplasticity: A review of preclinical and clinical studies Read More James Hawkins 24/05/2025 James Hawkins 24/05/2025 LSD for anxiety and depression: Worth the trip? Read More Newer Posts Older Posts
James Hawkins 01/07/2025 James Hawkins 01/07/2025 Beckley’s 5-MeO-DMT shows rapid, durable antidepressant effects in phase 2b study Read More
James Hawkins 23/06/2025 James Hawkins 23/06/2025 An investigation into the varieties of extended difficulties following psychedelic drug use: Duration, severity and helpful coping strategies Read More
James Hawkins 23/06/2025 James Hawkins 23/06/2025 Long-term mental health and wellbeing outcomes associated with naturalistic ayahuasca consumption Read More
James Hawkins 22/06/2025 James Hawkins 22/06/2025 Shamanism and psychedelics: 5 questions for Manvir Singh Read More
James Hawkins 22/06/2025 James Hawkins 22/06/2025 MAPS brings MDMA-assisted therapy to the war in Ukraine Read More
James Hawkins 18/06/2025 James Hawkins 18/06/2025 An international Delphi consensus for reporting of setting in psychedelic clinical trials Read More
James Hawkins 18/06/2025 James Hawkins 18/06/2025 Long-term benefits of single-dose psilocybin in depressed patients with cancer Read More
James Hawkins 08/06/2025 James Hawkins 08/06/2025 Psychedelic-assisted therapy: An overview for the internist Read More
James Hawkins 08/06/2025 James Hawkins 08/06/2025 Addressing blinding in classic psychedelic studies with innovative active placebos Read More
James Hawkins 08/06/2025 James Hawkins 08/06/2025 The Afterglow Inventory (AGI): Validation of a new instrument for measuring subacute effects of classic serotonergic psychedelics Read More
James Hawkins 01/06/2025 James Hawkins 01/06/2025 Systematic review of the effect of psychedelic-assisted therapy on … symptoms of distress, depression, and/or anxiety in patients with life-threatening illness Read More
James Hawkins 01/06/2025 James Hawkins 01/06/2025 Effects of psilocybin on religious and spiritual attitudes and behaviors in clergy from various major world religions Read More
James Hawkins 01/06/2025 James Hawkins 01/06/2025 Catalyst for change: Psilocybin’s antidepressant mechanisms — A systematic review Read More
James Hawkins 31/05/2025 James Hawkins 31/05/2025 Impact analysis of expanded access to ketamine for treatment-resistant depression Read More
James Hawkins 31/05/2025 James Hawkins 31/05/2025 Therapeutic emergence of dissociated traumatic memories during psilocybin treatment for anorexia nervosa Read More
James Hawkins 31/05/2025 James Hawkins 31/05/2025 Psychedelics and nature connectedness: Potential for restoring a lost relationship Read More
James Hawkins 24/05/2025 James Hawkins 24/05/2025 MDMA-assisted therapy for couples: Screening, preparation, and practice Read More
James Hawkins 24/05/2025 James Hawkins 24/05/2025 Reduced brain responsiveness to emotional stimuli with escitalopram but not psilocybin therapy for depression Read More
James Hawkins 24/05/2025 James Hawkins 24/05/2025 Psilocybin and neuroplasticity: A review of preclinical and clinical studies Read More
James Hawkins 24/05/2025 James Hawkins 24/05/2025 LSD for anxiety and depression: Worth the trip? Read More
